Jacot, W., Cottu, P., Berger, F., Dubot, C., Venat-Bouvet, L., Lortholary, A., . . . Bidard, F. (2019). Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: The CirCe T-DM1 trial. Breast Cancer Res.
Citación estilo ChicagoJacot, William, et al. "Actionability of HER2-amplified Circulating Tumor Cells in HER2-negative Metastatic Breast Cancer: The CirCe T-DM1 Trial." Breast Cancer Res 2019.
Cita MLAJacot, William, et al. "Actionability of HER2-amplified Circulating Tumor Cells in HER2-negative Metastatic Breast Cancer: The CirCe T-DM1 Trial." Breast Cancer Res 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.